Cargando…
Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples
BACKGROUND: More than 3 y into the coronavirus 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to undergo mutations. In this context, the Receptor Binding Domain (RBD) is the most antigenic region among the SARS-CoV-2 Spike protein and has emerged as...
Autores principales: | Raoufi, Ehsan, Hosseini, Fatemeh, Onagh, Bahman, Salehi-Shadkami, Mohammad, Mehrali, Marjan, Mohsenzadegan, Monireh, Ho, Jim Q., Bigdelou, Banafsheh, Sepand, Mohammad Reza, Webster, Thomas J., Zanganeh, Steven, Farajollahi, Mohammad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985519/ https://www.ncbi.nlm.nih.gov/pubmed/36871661 http://dx.doi.org/10.1016/j.cca.2023.117279 |
Ejemplares similares
-
Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review
por: Raoufi, Ehsan, et al.
Publicado: (2019) -
In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless
por: Shahrabi Farahani, Mahboube, et al.
Publicado: (2019) -
Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy
por: Mohsenzadegan, Monireh, et al.
Publicado: (2015) -
Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
por: Bakhshi, Parisa, et al.
Publicado: (2023) -
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
por: Bigdelou, Banafsheh, et al.
Publicado: (2022)